|
| Biotinylated Cynomolgus CD24 Protein (Primary Amine Labeling) (LTP10260) |
|
| LTP10260 |
|
| 100ug |
|
|
$789 In stock |
| CD24 is a sialoglycoprotein expressed at the surface of most B lymphocytes and differentiating neuroblasts. It is also expressed on neutrophils and neutrophil precursors from the myelocyte stage onwards. The potential for targeting CD24 in cancer therapy seems promising, as CD24 is overexpressed in many human cancers. |
| Recombinant Biotinylated Cynomolgus CD24 Protein (Primary Amine Labeling) is expressed from Expi293 with hFc tag at the C-terminal. It contains Thr27-Lys54. |
|
| CD24 |
|
| Cynomolgus |
|
| I7GKK1-1 |
|
| Thr27-Lys54 |
|
| The protein has a predicted MW of 30.2 kDa. Due to glycosylation, the protein migrates to 50-58 kDa based on the Tris-Bis PAGE result. |
|
| 0 |
|
| C-hFc |
|
| Expi293 |
|
| > 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC |
|
| Less than 1EU per ug by the LAL method. |
|
| Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as a protectant before lyophilization. |
|
| Reconstituted protein stable at -80 C for 12 months, 4 C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
|
| Shipped at ambient temperature. |
|
| Centrifuge tubes before opening. Reconstituting to a concentration of more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
|
|  |
